New Startup Raises $106M to Treat Schizophrenia, Epilepsy

A new biotech company just launched with $106 million to bring promising brain disorder treatments to Americans.

Tortugas Neuroscience is testing four drugs for conditions that affect millions, including schizophrenia, tinnitus, and epilepsy.